← Back to catalogue

LiquidQC CoV-2 IgG Control

FDA UDI

Class I (US FDA UDI)

by Cliniqa Corporation

Identity

Trade Name
LiquidQC CoV-2 IgG Control FDA UDI
Generic Name
SARS-CoV-2 immunoglobulin G (IgG) antibody IVD, control FDA UDI
Device Name
CLINIQA Liquid QCTM CoV-2 IgG Control an un-assayed quality control material for SARS-CoV-2 IgG assays. FDA UDI
Model / Reference
91494 FDA UDI
Description
CLINIQA Liquid QCTM CoV-2 IgG Control an un-assayed quality control material for SARS-CoV-2 IgG assays. FDA UDI

Identifiers

Primary DI / UDI-DI
00817238010035 FDA UDI
FDA Product Code
JJX FDA UDI
GMDN Term
SARS-CoV-2 immunoglobulin G (IgG) antibody IVD, control FDA UDI

Classification

Device Class
Class I FDA UDI
Regulation Number
862.1660 FDA UDI
Commercial Distribution
Not in Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

No

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

No

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

No

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

Yes

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

No

FDA UDI

LiquidQC CoV-2 IgG Control by Cliniqa Corporation — Class I — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Manufacturer
Cliniqa Corporation

Sources (1)

  • FDA UDI 817fc778-bba2-4327-b5a9-201abb1f5fc6 34 fields · synced May 30, 2026